Plants are widely used in many indigenous systems of medicine for therapeutic purposes and are increasingly becoming popular in modern society as alternatives to synthetic medicines. Bioactive principles are derived from the products of plant primary metabolites, which are associated with the process of photosynthesis. The present review highlighted the chemical diversity and medicinal potentials of bioactive principles as well inherent toxicity concerns associated with the use of these plant products, which are of relevance to the clinician, pharmacist or toxicologist. Plant materials are composed of vast array of bioactive principles of which their isolation, identification and characterization for analytical evaluation requires expertise with cutting edge analytical protocols and instrumentations. Bioactive principles are responsible for the therapeutic activities of medicinal plants and provide unlimited opportunities for new drug leads because of their unmatched availability and chemical diversity. For the most part, the beneficial or toxic outcomes of standardized plant extracts depend on the chemical peculiarities of the containing bioactive principles.

No abstract

Inhibition of dehydrogenase activity in pathogenic bacteria isolates by aqueous extract from the unripe fruit peels (called the bark) and leaves of Musa paradisiaca var sapientum were investigated via dehydrogenase assay using 2,3,5-triphenyl tetrazolium chloride (TTC) as the electron acceptor. Pure cultures of Staphylococcus and Pseudomonas species were exposed to varied concentrations of the extract [0-2000 µg/ml]. The extracts exhibited concentration dependent response against the tested organisms. Dehydrogenase activities (mg Formazan/mg cell dry weight/h) in the Gram-positive Staphylococcus sp. and Gram-negative Pseudomonas sp. were 1.125 ± 0.056 and 0.740 ± 0.040, respectively, and were progressively inhibited in the pure cultures. Threshold inhibitory concentrations (IC 50) of M. paradisiaca bark extract were 143.5 and 183.1 µg/ml against Staphylococcus and Pseudomonas species, respectively, while the threshold inhibitory concentrations (IC 50) of M. paradisiaca leaf extract were 401.2 and 594.6 µg/ml, respectively. The IC 100 of the leaf extract against Staphylococcus and Pseudomonas species were 1850 and 2000 µg/ml respectively, while the bark could not completely inhibit the organisms at the tested concentrations. The bark and leaves of M. paradisiaca may be an available source of raw material for the production of chemotherapeutic agents against pathogenic bacteria.

No abstract

No abstract

The calcium (Ca), zinc (Zn) and phytate contents of raw, boiled, and boiled plus 72 h fermented samples of four lesser-known African seeds – Citrullus colocynthis, Cucumeropsis edulis, Ricinus communis  and Prosopis africana – locally used for production of condiments in Nigeria were evaluated. Zinc bioavailability of the samples were also estimated using molar ratios per kg dry weight of [phytate]:[Zn], [Ca]:[phytate] and [phytate][Ca]:[Zn]. The levels of phytate, Zn and Ca of the raw seed samples varied from 150.01 ± 11.00 mg/100g (C. colocynthis) to 170.10 ± 10.01 mg/100g (C. edulis), 1.22 ± 0.10 mg/100g (C. colocynthis) to 4.79 ± 0.14 mg/100g (R. communis), and 28.33 ± 2.58 mg/100g (C. colocynthis) to 98.24 ± 15.19 mg/100g (R. communis) respectively. The calculated values of [phytate]:[Zn], [Ca]:[phytate] and [phytate][Ca]:[Zn] molar ratios for the raw seeds indicated that the samples have low Zn bioavailability. However, a combined processing technique of boiling and fermentation together, unlike boiling alone, significantly (p<0.05) improved these molar ratio markers, indicating high Zn bioavailability in condiments produced from these seeds.  The implications of these findings with regards to management of Zn deficiency and the superabundance of these seeds are enormous.

No abstract

No abstract